To include your compound in the COVID-19 Resource Center, submit it here.

BMS, Ono partner for prostaglandin receptor antagonist

Ono Pharmaceutical Co. Ltd. (Tokyo:4528) granted Bristol-Myers Squibb Co. (NYSE:BMY) exclusive rights to develop

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE